Recombinant Humanized Thyroid Stimulating Hormone (rhTSH ...

More documents

Recommendations

Info

CED-SOS ADVICE REPORT #5study), and the other study (11) found that QOL was worse in the hypothyroid patients on six ofthe 14 symptoms of hypothyroidism compared to baseline. The POMS was used in two studies(8,15) and demonstrated that QOL was significantly worse for the hypothyroid group in five ofthe six (p not reported) (15) and six of the six (p
CED-SOS ADVICE REPORT #5FundingThe PEBC is supported by Cancer Care Ontario (CCO) and the Ontario Ministry of Health and Long-TermCare. All work produced by the PEBC is editorially independent from its funding agencies.CopyrightThis evidence-based series is copyrighted by Cancer Care Ontario; the series and the illustrations hereinmay not be reproduced without the express written permission of Cancer Care Ontario. Cancer CareOntario reserves the right at any time, and at its sole discretion, to change or revoke this authorization.DisclaimerCare has been taken in the preparation of the information contained in this document. Nonetheless, anyperson seeking to apply or consult the evidence-based series is expected to use independent medicaljudgment in the context of individual clinical circumstances or seek out the supervision of a qualifiedclinician. Cancer Care Ontario makes no representation or guarantees of any kind whatsoever regardingtheir content or use or application and disclaims any responsibility for their application or use in any way.Contact InformationFor further information about this series, please contact Dr. John Yoo, London Health Sciences Centre,800 Commissioners Road East, London, Ontario, N6A 4G5; TEL (519)685-8457; FAX (519)685-8567;EMAIL john.yoo@lhsc.on.caFor information about the PEBC and the most current version of all reports,please visit the CCO Web site at http://www.cancercare.on.ca/ or contact the PEBC office at:Phone: 905-525-9140, ext. 22055 Fax: 905-522-7681SYSTEMATIC REVIEW– page 12
Page 1 and 2: CED-SOS ADVICE REPORT #5CED-SOS Adv
Page 3 and 4: CED-SOS ADVICE REPORT #5Key Evidenc
Page 5 and 6: CED-SOS ADVICE REPORT #5Genzyme Cor
Page 7 and 8: CED-SOS ADVICE REPORT #5In all four
Page 9 and 10: CED-SOS ADVICE REPORT #5Table 4: Ra
Page 11 and 12: CED-SOS ADVICE REPORT #5Table 6. Io
Page 13: CED-SOS ADVICE REPORT #5DISCUSSIONA
Page 17: CED-SOS ADVICE REPORT #517. Cooper

Recombinant Humanized Thyroid Stimulating Hormone (rhTSH ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?